These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30714283)

  • 1. Ovarian function after allogeneic hematopoietic stem cell transplantation in children and young adults given 8-Gy total body irradiation-based reduced-toxicity myeloablative conditioning.
    Komori K; Hirabayashi K; Morita D; Hara Y; Kurata T; Saito S; Tanaka M; Yanagisawa R; Sakashita K; Koike K; Nakazawa Y
    Pediatr Transplant; 2019 May; 23(3):e13372. PubMed ID: 30714283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignancies.
    Hirabayashi K; Nakazawa Y; Sakashita K; Kurata T; Saito S; Yoshikawa K; Tanaka M; Yanagisawa R; Koike K
    Sci Rep; 2014 Nov; 4():6942. PubMed ID: 25373730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence.
    Vatanen A; Wilhelmsson M; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
    Eur J Endocrinol; 2014 Feb; 170(2):211-8. PubMed ID: 24179099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplantation.
    Bender JD; Oquendo-Del Toro H; Benoit J; Howell JC; Badia P; Davies SM; Grimley MS; Jodele S; Phillips C; Burns K; Marsh R; Nelson A; Wallace G; Dandoy CE; Pate A; Strine AC; Frias O; Breech L; Rose SR; Hoefgen H; Khandelwal P; Myers KC
    Transplant Cell Ther; 2023 Feb; 29(2):130.e1-130.e8. PubMed ID: 36323400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding.
    Nakano H; Ashizawa M; Akahoshi Y; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y
    Int J Hematol; 2016 Jul; 104(1):110-6. PubMed ID: 27084256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric evaluation of ovaries and pelvic bones associated with clinical outcomes in patients receiving total body irradiation with ovarian shielding.
    Akahane K; Shirai K; Wakatsuki M; Suzuki M; Hatanaka S; Takahashi Y; Kawahara M; Ogawa K; Takahashi S; Oyama-Manabe N; Ashizawa M; Kimura SI; Kako S; Kanda Y
    J Radiat Res; 2021 Sep; 62(5):918-925. PubMed ID: 34350969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uterine volume is dramatically decreased after hematopoietic stem cell transplantation during childhood regardless of the conditioning regimen.
    Courbiere B; Drikes B; Grob A; Hamidou Z; Saultier P; Bertrand Y; Gandemer V; Plantaz D; Plat G; Poirée M; Ducassou S; Pochon C; Dalle JH; Thouvenin S; Paillard C; Kanold J; Sirvent A; Rousset-Jablonski C; Duros S; Gueniffey A; Cohade C; Boukaidi S; Frantz S; Agopiantz M; Poirot C; Genod A; Pirrello O; Gremeau AS; Bringer-Deutsch S; Auquier P; Michel G
    Fertil Steril; 2023 Apr; 119(4):663-672. PubMed ID: 36627013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
    Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
    Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian tissue cryopreservation for fertility preservation before hematopoietic stem cell transplantation in patients with sickle cell disease: safety, ovarian function follow-up, and results of ovarian tissue transplantation.
    Missontsa MM; Bernaudin F; Fortin A; Dhédin N; Pondarré C; Yakouben K; Neven B; Castelle M; Cavazzana M; Lezeau H; Peycelon M; Paye-Jaouen A; Sroussi J; Diesch-Furlanetto T; Barraud-Lange V; Sarnacki S; Fahd M; Marchand I; Delcour C; Vexiau D; Arlet JB; Kamdem A; Arnaud C; Dalle JH; Poirot C
    J Assist Reprod Genet; 2024 Apr; 41(4):1027-1034. PubMed ID: 38358434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning.
    Phelan R; Mann E; Napurski C; DeFor TE; Petryk A; Miller WP; Wagner JE; Verneris MR; Smith AR
    Bone Marrow Transplant; 2016 Oct; 51(10):1369-1375. PubMed ID: 27272448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated Clinical Outcomes of Hematopoietic Stem Cell Transplantation Using Myeloablative Total Body Irradiation with Ovarian Shielding to Preserve Fertility.
    Ashizawa M; Akahoshi Y; Nakano H; Kawamura S; Takeshita J; Yoshino N; Misaki Y; Yoshimura K; Gomyo A; Tamaki M; Kusuda M; Kameda K; Wada H; Kawamura K; Sato M; Terasako-Saito K; Tanihara A; Kimura SI; Nakasone H; Kako S; Akahane K; Wakatsuki M; Shirai K; Kanda Y
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2461-2467. PubMed ID: 31394267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian insufficiency following allogeneic hematopoietic stem cell transplantation.
    Kawano M; Komura H; Kawaguchi H; Shimizu S; Yada-Hashimoto N; Shimizu M; Sato M; Inoue M; Ida S; Etani Y; Shoji Y; Nakacho M; Sawada K; Kimura T; Mitsuda N; Kurachi H
    Gynecol Endocrinol; 2017 Feb; 33(2):156-159. PubMed ID: 27808585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pubertal outcomes of children transplanted with allogeneic stem cells after myeloablative total body irradiation or busulfan: Influence of age and sex is confirmed, while a role of chronic graft-versus-host disease in delayed puberty onset is revealed.
    Weinhard S; Wiedemann A; Leheup B; Dalle JH; Lebon Labich B; Pochon C
    Pediatr Transplant; 2020 Sep; 24(6):e13773. PubMed ID: 32701220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning.
    Abugideiri M; Nanda RH; Butker C; Zhang C; Kim S; Chiang KY; Butker E; Khan MK; Haight AE; Chen Z; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):349-59. PubMed ID: 26853343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow-up analysis of sex hormone levels and prognosis in women after hematopoietic stem cell transplantation].
    Xu QW; Du YY; Lyu KK; Xu MM; Gu CY; Kang HZ; Feng SL; Liu YJ; Wu DP; Han Y
    Zhonghua Nei Ke Za Zhi; 2023 Nov; 62(11):1303-1310. PubMed ID: 37935496
    [No Abstract]   [Full Text] [Related]  

  • 17. Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?
    Meacham LR; George S; Veludhandi A; Pruett MC; Haight AE; Arnold SD; Elchuri S; Stenger E; Krishnamurti L
    Transplant Cell Ther; 2023 Aug; 29(8):531.e1-531.e4. PubMed ID: 37169288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloablative versus Reduced-Intensity Conditioning in Patients with Myeloid Malignancies: A Propensity Score-Matched Analysis.
    Sibai H; Falcone U; Deotare U; Michelis FV; Uhm J; Gupta V; Kuruvilla J; Lipton JH; Seftel MD; Messner HA; Kim DDH
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2270-2275. PubMed ID: 27596129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.
    Forgeard N; Jestin M; Vexiau D; Chevillon F; Ricadat E; Peffault de Latour R; Robin M; Sicre de Fontbrune F; Xhaard A; Michonneau D; Boissel N; Poirot C; Dhédin N
    Transplant Cell Ther; 2021 May; 27(5):432.e1-432.e6. PubMed ID: 33789835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.